The digital pathology market is poised to reach USD 679.1 Million by 2021, growing at a CAGR of 12.1% during the forecast period of 2016 to 2021.
The growth of the overall market can be contributed to the rising cancer prevalence, increasing tele-consultations, utilization of digital pathology for drug discovery and companion diagnostics, and increasing government and industry player's initiatives into the pathological services. However, stringent regulatory concerns for primary diagnosis and lack of standard guidelines for digital pathology are likely to hamper the growth of the market.
North America is estimated to account for the largest share of the global digital pathology market. Increasing cancer prevalence, rising demand for quality diagnostics, favorable reimbursement policies, and initiatives undertaken by governments are some of the key factors driving the growth of the market in North America. Europe is expected to account for the second-largest share of the market. A majority of the leading players in the market are pursuing the strategies of new product launches, collaborations, and partnerships.
In the coming years, the digital pathology market is expected to witness the highest growth in the Asia-Pacific region, with emphasis on China, Japan, India and the Rest of Asia-Pacific. However, the Asia-Pacific region is expected to grow at the highest CAGR during the forecast period. Factors such as large patient population, shortage of pathologists, increasing initiatives in the healthcare industry by key market players, and rising adoption of advanced technologies for disease diagnosis are driving the growth of the market in this region.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Digital Pathology Market, By Product
7 Digital Pathology Market, By Type
8 Digital Pathology Market, By End User
9 Digital Pathology Market, By Application
10 Global Digital Pathology Market, By Region
11 Competitive Landscape
12 Company Profiles
- 3D Histech Ltd. (Hungary)
- Apollo Enterprise Imaging Corp. (U.S.)
- Corista LLC (U.S.)
- Definiens AG (Germany)
- Hamamatsu Photonics K.K (Japan)
- Leica Biosystems Nussloch GMBH (Germany)
- Omnyx LLC. (U.S.)
- Philips Healthcare (Netherlands)
- Ventana Medical Systems Inc. (U.S.)
- Visiopharm A/S (Denmark)
- Xifin Inc. (U.S.)
For more information visit http://www.researchandmarkets.com/research/zthfld/digital_pathology